Cholangiopathy as part of post-COVID syndrome

Manuel Rojas; Yhojan Rodríguez; Elizabeth Zapata; Juan Carlos Hernández; Juan-Manuel Anaya

doi:10.1016/j.jtauto.2021.100116

Cholangiopathy as part of post-COVID syndrome

Manuel Rojas, Yhojan Rodríguez, Elizabeth Zapata, Juan Carlos Hernández, Juan-Manuel Anaya

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

15 Citas (Scopus)

Resumen

Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this condition in patients with COVID-19.

Idioma original	Inglés estadounidense
Número de artículo	100116
Páginas (desde-hasta)	1-3
Número de páginas	3
Publicación	Journal of Translational Autoimmunity
Volumen	4
Fecha en línea anticipada	ago. 31 2021
DOI	https://doi.org/10.1016/j.jtauto.2021.100116
Estado	Publicada - 2021

Áreas temáticas de ASJC Scopus

Enfermedades infecciosas

Acceder al documento

10.1016/j.jtauto.2021.100116

Citar esto

@article{a77c265109574753a68bec7646e5b8b0,

title = "Cholangiopathy as part of post-COVID syndrome",

abstract = "Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this condition in patients with COVID-19.",

author = "Manuel Rojas and Yhojan Rodr{\'i}guez and Elizabeth Zapata and Hern{\'a}ndez, {Juan Carlos} and Juan-Manuel Anaya",

note = "{\textcopyright} 2021 The Authors.",

year = "2021",

doi = "10.1016/j.jtauto.2021.100116",

language = "English (US)",

volume = "4",

pages = "1--3",

journal = "Journal of Translational Autoimmunity",

issn = "2589-9090",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Cholangiopathy as part of post-COVID syndrome

AU - Rojas, Manuel

AU - Rodríguez, Yhojan

AU - Zapata, Elizabeth

AU - Hernández, Juan Carlos

AU - Anaya, Juan-Manuel

PY - 2021

Y1 - 2021

N2 - Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this condition in patients with COVID-19.

AB - Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this condition in patients with COVID-19.

U2 - 10.1016/j.jtauto.2021.100116

DO - 10.1016/j.jtauto.2021.100116

M3 - Article

C2 - 34485887

SN - 2589-9090

VL - 4

SP - 1

EP - 3

JO - Journal of Translational Autoimmunity

JF - Journal of Translational Autoimmunity

M1 - 100116

ER -

Cholangiopathy as part of post-COVID syndrome

Resumen

Áreas temáticas de ASJC Scopus

Acceder al documento

Huella

Citar esto